4//SEC Filing
Freund John Gordon 4
Accession 0001062993-22-013302
CIK 0001267565other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:44 PM ET
Size
7.5 KB
Accession
0001062993-22-013302
Insider Transaction Report
Form 4
Freund John Gordon
Director
Transactions
- Award
Common Stock
2022-05-19+14,035→ 34,983 total
Holdings
- 8,625(indirect: By LLC)
Common Stock
- 34,788(indirect: By Partnership)
Common Stock
Footnotes (3)
- [F1]Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 19, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.
- [F2]The shares are held by Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management V, LLC. The reporting person disclaims beneficial ownership of all the shares held by Skyline Venture Management V, LLC except to the extent of his proportionate pecuniary interest therein.
- [F3]The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The reporting person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The reporting person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001296771
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:44 PM ET
- Size
- 7.5 KB